comparemela.com

Page 3 - Uk Azn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sell AstraZeneca, says UBS, which upgrades European rivals including GSK

UBS analysts shook up their ratings of European drugmakers, including making a double-downgrade of AstraZeneca and a double-upgrade of U.K. rival GSK.

City ofUnited kingdomNovo nordiskMatthew westonArticle normalBiotechnology servicesHealthcare life sciencesAerospace defenseDefense equipment productsIndustrial goodsCorporate strategy planningAnalyst comment recommendationCorporate industrial newsContent typesFactiva filtersC amp ampe exclusion filter

U K stocks drop for first time in two days

U.K. stocks finished down Tuesday, with the FTSE 100 Index dropping 0.15% at 7,721.52. Among FTSE 100 constituents, precious metals company Fresnillo PLC saw.

James placeArticle normalMetal ore miningSilver ore miningPrimary metalsTelecommunication servicesWireless telecommunications servicesMobile telecommunicationsBasic materials resourcesMining quarryingNon ferrous metal ore miningFinancial performanceCorporate industrial newsEquity marketsCommodity financial market newsContent types

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

Obesity and diabetes companies soared this year, while the rest of pharma did poorly

Eli lillyNovo nordiskCharlotte de la fuenteWall streetPharmaceutical indexWsjfinance marketsCancer drugsHealthcare life sciencesSpecialized drugs medicationsCorporate industrial newsPolitical general newsSociety communityMedical conditionsSocial issuesWsj pro comBristol myers squibb

AstraZeneca to Buy China s Gracell in $1 2 Billion Deal

AstraZeneca’s acquisition of Gracell is expected to close in te first quarter of 2024.

United statesAngela palumboSusan galbraithGetty imagesGracell biotechnologiesArticle normalBiotechnology servicesHealthcare life sciencesBiological therapyHealthcare provisionOwnership changesAcquisitions mergers shareholdingsAcquisitions mergersCorporate actionsCorporate industrial newsContent types

Biotech Stocks Are Breaking Out—and They Show No Sign of Slowing Down

Biotech stocks have gotten a boost from the Fed and from M&A.

Katie stocktonBristol myersBen levisohnFederal reserveShares biotechnologyFairlead strategie katieArticle normalBiotechnology servicesTrusts funds financial vehiclesHealthcare life sciencesExchange traded fundsFinancial servicesInvesting securitiesPolitical general newsSciences humanitiesMarkets now

vimarsana © 2020. All Rights Reserved.